Skip to main content

Advertisement

Table 1 Immunohistochemical scores for KLK1, KLK6, KLK7, KLK8, KLK9 and KLK10 in astrocytoma patients

From: Prognostic significance of multiple kallikreins in high-grade astrocytoma

  Intensity ± SD Percent ± SD IR ± SD
  III IV P a III IV P a III IV P a
KLK1 1.7 ± 0.4 2.2 ± 0.4 0.0063** 3.7 ± 0.4 3.3 ± 0.7 0.096 5.4 ± 1.8 7.3 ± 2.4 0.031*
KLK6 1.5 ± 0.7 2.6 ± 0.4 0.0003*** 2.0 ± 0.6 3.0 ± 0.7 0.0005*** 2.4 ± 1.5 7.7 ± 2.4 <0.0001***
KLK7 2.0 ± 0.1 2.3 ± 0.4 0.0042** 3.9 ± 0.2 3.7 ± 0.4 0.057 5.9 ± 1.1 8.2 ± 2.1 0.003**
KLK8 1.1 ± 0.2 1.5 ± 0.5 0.0099** 3.8 ± 0.5 3.0 ± 0.8 0.0038** 3.0 ± 0.7 4.3 ± 1.6 0.022*
KLK9 1.4 ± 0.6 2.4 ± 0.5 0.0003*** 3.4 ± 0.7 3.6 ± 0.5 0.42 4.6 ± 1.8 9.0 ± 1.9 0.0001***
KLK10 1.0 ± 0.0 1.4 ± 0.4 0.0012** 2.5 ± 1.2 3.0 ± 0.7 0.36 2.4 ± 1.4 3.9 ± 1.5 0.011*
  1. Mean and standard deviation of KLK1, KLK6, KLK7, KLK8, KLK9 and KLK10 staining intensity, percent tumor core stained and immunoreactivity score across 60 grade IV astrocytoma specimens
  2. *P < 0.05, **P < 0.01 and ***P < 0.001
  3. aKruskal-Wallis test